These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17198068)

  • 1. Should antihepatitis B virus core positive or antihepatitis C virus core positive subjects be accepted as organ donors for liver transplantation?
    Gallegos-Orozco JF; Vargas HE
    J Clin Gastroenterol; 2007 Jan; 41(1):66-74. PubMed ID: 17198068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B core antibody-positive grafts: recipient's risk.
    de Villa VH; Chen YS; Chen CL
    Transplantation; 2003 Feb; 75(3 Suppl):S49-53. PubMed ID: 12589141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor pool expansion in liver transplantation.
    Montalti R; Nardo B; Bertelli R; Beltempo P; Puviani L; Vivarelli M; Cavallari A
    Transplant Proc; 2004 Apr; 36(3):520-2. PubMed ID: 15110578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
    Yu L; Koepsell T; Manhart L; Ioannou G
    Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of hepatitis B core antibody positivity in donors for liver transplantation in Saudi Arabia.
    Al-Sebayel MI; Khalaf HA; Ramirez CG
    Saudi Med J; 2002 Mar; 23(3):298-300. PubMed ID: 11938420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of de novo hepatitis B virus infection by vaccination and high hepatitis B surface antibodies level in children receiving hepatitis B virus core antibody-positive living related donor liver: case reports.
    Jankowska I; Pawłowska J; Teisseyre M; Kaliciński P; Kamiński A; Czubkowski P; Cielecka-Kuszyk J; Kluge P; Pronicki M; Socha J
    Transplant Proc; 2007 Jun; 39(5):1511-2. PubMed ID: 17580175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended criteria donors in liver transplantation: adapting donor quality and recipient.
    Gastaca M
    Transplant Proc; 2009 Apr; 41(3):975-9. PubMed ID: 19376402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation using donors older than 80 years: a single-center experience.
    Petridis I; Gruttadauria S; Nadalin S; Viganò J; di Francesco F; Pietrosi G; Fili' D; Montalbano M; D'Antoni A; Volpes R; Arcadipane A; Vizzini G; Gridelli B
    Transplant Proc; 2008; 40(6):1976-8. PubMed ID: 18675105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for de novo hepatitis B from antibody to hepatitis B core antigen-positive donors in liver transplantation in Singapore.
    Lee KH; Wai CT; Lim SG; Manjit K; Lee HL; Da Costa M; Quak SH; Tan KC
    Liver Transpl; 2001 May; 7(5):469-70. PubMed ID: 11349271
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of hepatitis B core antibody-positive donor livers does not appear to have a deleterious effect on graft survival in liver transplantation for hepatitis C.
    Rayhill S; Schwartz J; Ham J; Carithers R; Lei Y; Bhattacharya R; Liou I; Landis C; Lamaye A; Rakita R; Dick A; Healey P; Halldorson J; Bhakthavatsalam R; Perkins J; Reyes J
    Transplant Proc; 2010 Dec; 42(10):4141-4. PubMed ID: 21168646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections transmitted from donors to recipients following organ transplantation.
    Rao YG; Mirza DF
    Natl Med J India; 2005; 18(4):189-94. PubMed ID: 16252549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risks of HBV infection after liver transplantation from HBc antibody positive donor to HBs antibody positive recipient.
    Ikegami T; Taketomi A; Ohta R; Soejima Y; Yoshizumi T; Harada N; Shimada M; Maehara Y
    Hepatogastroenterology; 2008; 55(88):2162-5. PubMed ID: 19260497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver transplantation in Germany].
    Wolff M; Kalff JC; Schwarz NT; Lauschke H; Minor T; Tolba RH; Hirner A
    Zentralbl Chir; 2003 Oct; 128(10):831-41. PubMed ID: 14628232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients].
    Sugg U
    Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody to hepatitis B core antigen-positive grafts: not perfect but no longer marginal.
    Prieto M
    Liver Transpl; 2009 Oct; 15(10):1164-8. PubMed ID: 19790162
    [No Abstract]   [Full Text] [Related]  

  • 18. Hot topics in liver transplantation: organ allocation--extended criteria donor--living donor liver transplantation.
    Müllhaupt B; Dimitroulis D; Gerlach JT; Clavien PA
    J Hepatol; 2008; 48 Suppl 1():S58-67. PubMed ID: 18308415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of marginal grafts in liver transplantation.
    Hashimoto K; Miller C
    J Hepatobiliary Pancreat Surg; 2008; 15(2):92-101. PubMed ID: 18392701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver transplantation].
    Samuel D; Antonini TM
    Rev Prat; 2007 Feb; 57(3):280-6. PubMed ID: 17578028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.